The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II.
Open Access
- 1 May 1992
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 12 (5), 2250-2259
- https://doi.org/10.1128/mcb.12.5.2250
Abstract
We examined the ability of purified RNA polymerase (RNAP) II lacking the carboxy-terminal heptapeptide repeat domain (CTD), called RNAP IIB, to transcribe a variety of promoters in HeLa extracts in which endogenous RNAP II activity was inhibited with anti-CTD monoclonal antibodies. Not all promoters were efficiently transcribed by RNAP IIB, and transcription did not correlate with the in vitro strength of the promoter or with the presence of a consensus TATA box. This was best illustrated by the GC-rich, non-TATA box promoters of the bidirectional dihydrofolate reductase (DHFR)-REP-encoding locus. Whereas the REP promoter was transcribed by RNAP IIB, the DHFR promoter remained inactive after addition of RNAP IIB to the antibody-inhibited reactions. However, both promoters were efficiently transcribed when purified RNAP with an intact CTD was added. We analyzed a series of promoter deletions to identify which cis elements determine the requirement for the CTD of RNAP II. All of the promoter deletions of both DHFR and REP retained the characteristics of their respective full-length promoters, suggesting that the information necessary to specify the requirement for the CTD is contained within approximately 65 bp near the initiation site. Furthermore, a synthetic minimal promoter of DHFR, consisting of a single binding site for Sp1 and a binding site for the HIP1 initiator cloned into a bacterial vector sequence, required RNAP II with an intact CTD for activity in vitro. Since the synthetic minimal promoter of DHFR and the smallest REP promoter deletion are both activated by Sp1, the differential response in this assay does not result from upstream activators. However, the sequences around the start sites of DHFR and REP are not similar and our data suggest that they bind different proteins. Therefore, we propose that specific initiator elements are important for determination of the requirement of some promoters for the CTD.Keywords
This publication has 46 references indexed in Scilit:
- RNA polymerase II carboxy-terminal domain contributes to the response to multiple acidic activators in vitro.Genes & Development, 1991
- RNA POLYMERASE IIAnnual Review of Biochemistry, 1991
- A functional interaction between the C-terminal domain of RNA polymerase II and the negative regulator SIN1Cell, 1991
- RNA POLYMERASE B (II) AND GENERAL TRANSCRIPTION FACTORSAnnual Review of Biochemistry, 1990
- Phosphorylation of RNA polymerase by the murine homologue of the cell-cycle control protein cdc2Nature, 1989
- 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits a HeLa protein kinase that phosphorylates an RNA polymerase II-derived peptideBiochemical and Biophysical Research Communications, 1989
- Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elementsCell, 1988
- Functional redundancy and structural polymorphism in the large subunit of RNA polymerase IICell, 1987
- A method for freezing synchronous mitotic and G1 cellsExperimental Cell Research, 1987
- Purification using polyethylenimine precipitation and low molecular weight subunit analyses of calf thymus and wheat germ DNA-dependent RNA polymerase IIBiochemistry, 1977